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Abstract Sm3+-doped magnetic nanoparticles (NPs) were
prepared via microwave-assisted polyol synthesis in ethylene
glycol, poly(ethylene glycol) and mixed ethylene glycol—
poly(ethylene glycol) solutions. In present work, the effects
of organic solvent composition on particle size, particle size
distribution, extent of agglomeration, and samarium content in
prepared NPs were studied. The synthesized NPs were char-
acterized by several techniques as follows: X-ray diffraction
(XRD), transmission electron microscopy (TEM),
thermogravimetry (TGA) and X-Ray fluorescence (XRF)
analysis. XRD and TEM results showed formation of ~6.0–
17.9 nm NPs having different microstructure characteristics
(average particle size, particle size distribution, and agglom-
eration). The TGA analysis indicated the presence of organic
components on the surface of NPs. Cytotoxic activity of the
prepared magnetic NPs towards HeLa cells was evaluated by
using standard live/dead assay in comparison to a control so-
lution. It was shown that prepared magnetic NPs are charac-
terized by low toxicity that makes possible their use for bio-
medical applications.
Keywords Magnetic nanoparticles . HeLa cells . Polyol
synthesis . Microwave-assisted synthesis . Samarium-doped
nanoparticles . Iron oxide nanoparticles
1 Introduction
Due to their unique properties including high magnetic sensitiv-
ity, non-toxicity, and biocompatibility iron oxides NPs have
been widely used in different biomedical applications [1] such
as drug delivery [2], magnetic resonance imaging (MRI) con-
trast agents [3], cell labeling [4], theranostics [5]. Magnetite
(Fe3O4) and maghemite (γ-Fe2O3) are most widely used among
different types of ferromagnetic NPs [6]. Magnetite is a com-
bined Fe2+ and Fe3+ oxide with 1:2 ratio, which has an inverse
spinel structure consisting of octahedral and mixed tetrahedral/
octahedral layers stacked along the [111] plane where Fe3+ oc-
cupy tetrahedral positions and both Fe2+ and Fe3+ are sited in
octahedral ones [7, 8]. Maghemite has a cubic structure and can
be considered as fully oxidized magnetite [9]. Substitution of
Fe3+ by doping with rare earth elements can enhance magnetic
properties and increase their resistance to oxidation [10].
Major efforts have been devoted to the synthesis of iron
oxides NPs by using co-precipitation [11], microwave-
assisted [12], solvothermal [13], electrochemical [14] synthe-
sis, micro-emulsions [15] and high-temperature Fe-containing
organic compounds decomposition [16]. One of the promising
methods for NPs preparation is polyol synthesis. The polyol
technique was developed in 1980s by Fernand Fievet’s group
for the preparation of fine, highly pure, monodisperse, non-
agglomerated metal particles [17, 18]. Polyol process includes
three major steps: (1) dissolution of the powdered inorganic
metallic precursor in a liquid polyol (ethylene glycol,
diethylene glycol, triethylene glycol, propylene glycol, etc., or
a mixture of few glycols); (2) reduction of the metals ions by
the polyol; (3) nucleation of the metallic phase and growth of
the individual nuclei [17, 19]. During the procedure polyol can
play a triple role as a solvent, a reducing agent and a surfactant
[20]. However, frequently various surfactants are used to pre-
vent sintering of the NPs [21]. Polyol synthesis is
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environmentally friendly process because the reactions are car-
ried out under closed system conditions with using of low-toxic
organic solvents [22, 23]. Among the advantages that this
method presents, it should be mentioned that polyol techniques
allow controlling the NPs microstructure (size, shape, particle
size distributions, strains, etc.) by manipulating the synthesis
conditions: nature of polyol, addition of surfactants, tempera-
ture, pH, time of reduction reaction [24]. In addition, polyols
provide an opportunity to perform the synthesis procedure in
combination with other techniques, for example, microwave-
assisted [23] or solvothermal [25] methods.
In the present work, we describe a microwave-assisted
polyol synthesis of the Sm3+-doped magnetic NPs by using
of ethylene glycol, poly(ethylene glycol) and mixed ethylene
glycol/poly(ethylene glycol) solutions as polyol. Cytotoxicity
test towards HeLa cells showed their viability. This approach
for the synthesis can contribute to the development of biocom-
patible magnetic NPs preparation.
2 Experimental Part
2.1 Materials
Iron(III) chloride (FeCl3, 97%), ethylene glycol (EG, C2H6O2,
9 9 % ) , p o l y ( e t h y l e n e g l y c o l ) ( P E G , H O
−(CH2 − CH2 −O)n −H, BioUltra, 200) were purchased from
Sigma-Aldrich. Ultra dry samarium chloride (SmCl3, 99.9%
(REO)), sodium hydroxide (NaOH, 98%) were supplied from
Alfa Aesar. Chemicals and solvents were used without further
purification. Deionized (DI) water was obtained at Simplicity
UV system.
2.2 Synthesis
In a typical synthesis, FeCl3 (0.4 mmol) and SmCl3 (13 μmol)
were completely dissolved in 15 mL of polyol. The total
amount of SmCl3 was calculated from the assumption that
the molar ratio of Sm3+ ions obtained after SmCl3 dissolution
to total amount of Fe3+ and Sm3+ ions being 3.2%. Then,
2.4 mL of EG (or PEG in the case of the synthesis in 100%
v/v PEG media) containing 2.4 mmol NaOH was added. The
solution has been blowing with argon for 10 min to reduce
oxygen content. Prepared solution was heated in a MW-
reactor (Discover SP, CEM) for 90 min at 220 °C. After the
reaction vessel was cooled down to room temperature; a black
precipitate was washed several times with DI water, ethanol
and again with DI water, and separated by a magnet. Obtained
powder was dried in a vacuum oven at 60 °C overnight.
As a polyol reacted as solvent, reduction agent and stabi-
lizer pure EG, PEG, and different mixed solutions were used:
10% v/v PEG +90% v/v EG, 30% v/v PEG +70% v/v EG, 50%
v/v PEG +50% v/v EG, 70% v/v PEG +30% v/v EG.
2.3 Characterization of the Synthesized NPs
XRD patterns were collected with Ultima IV powder diffrac-
tometer (Rigaku) using Cu Kα radiation (α = 1.5406 Å) with
Fig. 1 XRD a patterns of Fe3O4 NPs prepared in different organic
solvents: 1 100% EG, 2 90% v/v EG + 10% v/v PEG, 3 70% v/v EG +
30% v/v PEG, 4 50% v/v EG + 50% v/v PEG, 5 30% v/v EG + 70% v/v
PEG, 6 100% PEG, dependence of the average particle size on the EG
content (b) and dependence of the Sm concentration on the EG content (c)
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a 0.02° 2θ step size and a 2-s dwell time from 25° to 90° of 2θ.
Operating power was 40 kVand 40 mA.
TEM images were acquired on JEM-2100 microscope
(JEOL) operated at an accelerating voltage of 200 kV.
Fig. 2 TEM image,
magnification of the particles and
particle size distribution
histogram for the NPs prepared
from a 100% EG solution, b 50%
v/v EG + 50% v/v PEG solution, c
100% PEG solution
Table 1 Average particle size
calculated from XRD results and
samarium content
Solution composition Dav [XRD] (nm) Lattice parameter (A) Sm content (wt.%)
100% EG 6.0 8.401 6.4
90% v/v EG + 10% v/v PEG 10.4 8.385 9.1
70% v/v EG + 30% v/v PEG 17.9 8.383 9.1
50% v/v EG + 50% v/v PEG 13.9 8.399 7.4
30% v/v EG + 70% v/v PEG 9.8 8.396 7.1
100% PEG 6.8 8.369 4.25
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Thermogravimetric analysis (TGA) and differential scan-
ning calorimetry (DSC) of samples were performed using a
SDT Q600TGA/DSC/DTA thermal analyzer. Samples were
heated from room temperature to 800 °C at 10 °C/min rate
under argon flow.
Elemental analysis (Fe, Sm) was carried out on M4
TORNADO Micro-XRF spectrometer (Bruker). The sample
powder was deposited on a surface of pressed boric acid disk.
Magnetic susceptibility measurements were performed
with a vibrating sample magnetometer (VSM) (Lake Shore
VSM 7400, USA) in the magnetic field range from −19,000
to 19,000 Oe at room temperature.
We used HeLa cell line as the cell model for toxicity tests.
The cells were subcultured in T25 flasks, and further cultured
for analysis in 96-well plates (SPL Lifesciences, South Korea)
in the GlutaMax DMEM medium (Thermo Fisher Scientific,
USA) supplemented with 10% of fetal bovine serum (GE
Healthcare, UK) and 0.05 μg/ml of gentamicin (Biokhimik
JSC, Russia). The cells were kept at 37 °C and 5% CO2, with
passive humidification in the Sanyo MCO-18 AC incubator
(Panasonic, Japan).
For cell viability assay, the nanoparticle formulations were
resuspended in physiological saline so as to reach final culture
medium concentration of 50 or 25 μg/mL. Cell viability was
assessed using the trypan blue exclusion assay in three differ-
ent days, two biological replicates per day, two technical rep-
licates per biological replicate for each nanoparticle sample.
Briefly, the 30,000–40,000 cells treated with the nanoparticle
formulations and control saline were detached with 0.25%
trypsin-EDTA solution and mixed with equal volume of
0.4% trypan blue (Thermo Fisher Scientific, USA) and, after
2 min of incubation, counted in the Goryaev chamber (the
chamber is analogous to the hemocytometer; Minimed LLC,
Russia) under a PrimoStar microscope (Carl Zeiss, Germany).
There were about 500 cells under a microscopic examination.
Cell viability data are presented as mean ± SD. The data
were analyzed for normality (the zero hypothesis was retained
in all cases) using Kolmogorov-Smirnov test and for statistical
Fig. 4 Magnetization curves of
the materials prepared in 100%
EG, 50% v/v EG + 50% v/v PEG,
and 100% PEG solutions
Fig. 3 TGA (a) and DSC (b) curves of the materials prepared in 100%
EG, 50% v/v EG + 50% v/v PEG, and 100% PEG solutions
BioNanoSci.
differences using both non-parametricMann-Whitney test and
parametric ANOVA. The tests were cross-consistent.
Statistical calculations were performed using the SPSS 22
package.
3 Results and Discussion
The XRD patterns for all samples are given in Fig. 1a. The
observed reflexes at 2θ degrees of 30, 35.4, 43.3, 53.6, 57.0,
and 62.6 indicated about a cubic spinel structure formation.
The average particle sizes calculated by Williamson-Hall
method are presented in Table 1.
It can be seen that average particle size depend on the
solution composition (Fig. 1b, Table 1). The biggest par-
ticles were prepared in the 70% v/v EG + 30% v/v PEG
and 50% v/v EG + 50% v/v PEG solutions. On the other
hand, the influence of another solvent on composition is
not such significant and allow preparing similar small
particles 6.0–10.4 nm in size. Moreover, samarium con-
tent depends on solvent composition. With increasing of
PEG concentration in solvent during synthesis samarium
content in the prepared NPs at the first stage enhances
and then, when the concentration of PEG is bigger than
30 v/v %, slowly reduces (Fig.1c, Table 1).
Results obtained from TEM indicated the formation of big
agglomerates with broad particle size distribution in the case
of NPs prepared from EG (Fig. 2a) and 50% v/v EG + 50% v/v
PEG (Fig. 2b) solutions. In contrast, synthesis in PEG solution
results in the formation of small well-defined NPs (Fig. 2c)
with narrow particle size distribution. Also, it can be noted
that synthesis in pure EG solution results in the formation of
homogeneous NPs with uniform spherical shape. It can
indicate that PEG is more efficient stabilizing agent for such
synthesis conditions.
Moreover, the average particle size values calculated from
XRD and TEM data for the NPs prepared in 100% EG and
50% v/v EG + 50% v/v PEG solutions are different, whereas
size values for the NPs prepared in 100% PEG solution are
similar for XRD and TEM results. This can be explained by a
variety of reasons. The first, an addition of PEG reduces the
solvent’s viscosity and may affect the nucleation of NPs.
Moreover, PEG differs from EG in boiling point and by re-
duction activity. As a result, the processes of partial reduction
of the Fe3+ ions into Fe2+ and formation of the magnetite NPs
proceed slowly in the solutions with high PEG concentration.
Figure 3 shows the TGA and DSC curves of the sam-
ples prepared in 100% EG solution, 50% v/v EG + 50%
v/v PEG solution and 100% PEG solution. The TG
curves consist of three typical stages: ~200–250, ~250–
560, and ~560–680 °C. Weight loss below 200 °C can be
attributed to the removal of bound water [26] and free
organic components from the surface of NPs [27]. The
next stage beginning at about 250 °C can be related to
the decomposition of the organic components directly
bent with magnetic NPs. According to the literature data,
small weight loss in the range of ~560–680 °C can be
explained by phase transition from Fe3O4 to FeO, be-
cause FeO is thermodynamically stable above ~570 °C
in phase diagram of the Fe–O system [28, 29] according
to the following Eq. [29]:
Fe3O4 →
Δ; −1=2 O2 3FeO ð1Þ
The quantities of the residue after thermal degradation of
the samples prepared in 100% EG solution, 50% v/v EG +
Table 2 Magnetic characteristics
of the prepared materials Sample Coercivity, Hc (Oe) Magnetization, Ms (emu/g) Remanence, Mr (emu/g)
100% EG 10 44.6 1.1
50% v/v EG + 50% v/v PEG 60 47.8 4.3
100% PEG 150 46.8 6.2
Table 3 Results of iron oxide
NPs cytotoxicity test towards
HeLa cell line
Sample Test solution
(μg/mL)
Number of
samples
Cell viability
(proportion ±
error of proportion)
MW p level;
ANOVA p levela
Control (NaCl) (0.89%) 10 0.79 ± 0.04 –
NPs from 100% EG solution 25 7 0.81 ± 0.03 0.151; 0.137
50 6 0.75 ± 0.04 0.062; 0.091
NPs from 100% PEG solution 25 7 0.83 ± 0.05 0.085; 0.060
50g/mL 6 0.77 ± 0.04 0.301; 0.377
aNote: the NPs test solutions are only compared to the control group
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50% v/v PEG solution and 100% PEG solution were 88, 91.4
and 91.6%, respectively. It can be observed that NPs prepared
from the solutions with higher PEG concentration are charac-
terized by the smaller percentage of the residual mass and by
the higher thermal stability.
Organic coating of NPs could have a significant impact on
their biomedical properties. The presence of PEG on the sur-
face of obtained NPs is not a negative factor. PEG is an im-
portant biocompatible polymer being often used as a coating
agent for the NPs applications in biomedicine [30, 31].
DSC results are in agreement with TGA data about the
three steps of thermal decomposition. The first exothermic
peak below 100 °C can be associated with the presence of
water in the materials. Than second region has two exothermic
peaks at ~290 and 365 °C for the material prepared in 100%
EG. For the samples 50% v/v EG + 50% v/v PEG and 100%
PEG solutions the second peak lays at ~420 °C. The occur-
rence of these two peaks attributed to the boiling and decom-
position of the organic molecules. The last peak in DSC is
located at ~620–640 °C for all three samples and can be as-
cribed to the phase transformation of iron oxide.
The magnetic properties of the NPs were investigated by
VSM analysis at room temperature (Fig. 4). The presence of
hysteresis indicates that these magnetic NPs are typical ferro-
magnetic materials. The values of the saturation magnetiza-
tion (Ms), the coercivity (Hc), and remanence (Mr), as defined
from the hysteresis loops, are shown in Table 2. It can be noted
that saturation magnetization increases with increase of mag-
netic particle size. The coercivity and remanence values in-
crease with increasing PEG content in solution.
As iron oxide NPs are promising agents for targeted
delivery-and-release as well as for theranostics, their own cy-
totoxicity is unwanted. The presence of organic compounds
on the surface of iron oxide can influence on the NPs cytotox-
icity. PEG is often used in many medicines administered by
the parenteral, topical, ophthalmic, oral and rectal routes [32].
Some drugs (Busuflex®, Vepesid®, Ativan®) contain PEG as
excipients. The World Health Organization (WHO) has set an
estimated acceptable daily dose of PEGs at up to 10 mg/kg of
body weight [33]. Moreover, PEG derivatives can include
residual ethylene oxide, 1,4-dioxane, polycyclic aromatic
compounds, and heavy metals [34]. EG is more toxic than
PEG, as indicated in [35] a tolerable intake of EG is
0.05 mg per kg of body weight per day.
The main benefits of using iron oxide NPs are true only
when their enhanced permeability and retention (EPR) effect
is coupled with capability to be locally activated by ultra-
sound, magnetic impulses, and heat. The EPR effect is never
absolute: the particles will always be distributed over the body
to some extent (not many carriers can deliver more than 5% of
the injected dose to tumor cells, the rest 95% resulting in
normal tissues). Thus, the lower the inherent cytotoxicity of
the iron oxide NPs, the better. What is more, better iron oxide
NPs are those activated as easy as possible, and this charac-
teristic depends mostly on their magnetic properties.
The toxicity test for the obtained iron oxide NPs has been
performed as a standard evaluation of acute toxicity towards
HeLa cells by using live/dead assays. The NPs formulations
were resuspended in physiological saline to reach final culture
medium concentration of 25 or 50 μg/mL. The averaged via-
bility proportion values are 0.81 and 0.75 for the NPs (in 25
and 50 μg/mL concentrations, respectively) prepared in 100%
EG solution, and 0.83 and 0.77 for the NPs prepared from
100% PEG solution (Table 3, Fig. 5).
The results obtained in the solutions with different NPs
concentration are the same and indicate about high values of
viability. Such results indicated low cytotoxicity of the pre-
pared NPs making them promising for the biomedical
application.
4 Conclusions
The present study demonstrates the influence of organic sol-
vent composition on the magnetic NPs particle size, particle
size distribution and extent of aggregation. The polyols EG,
PEG, and their mixture allow preparing different sizes NPs
ranging from 6.0 to 17.9 nm. TEM results indicated formation
of small, well-defined spherical NPs with narrow particle size
distribution in the case of synthesis in pure PEG. The particles
displayed low cytotoxicity towards HeLa cells that makes
possible their use for biomedical applications. It can be con-
cluded that microwave-assisted polyol synthesis in EG, PEG,
or mixed EG-PEG media results in stable, biocompatible, and
nontoxic NPs.
Fig. 5 Resulting cell viability of the cell line HeLa after incubation with
different concentrations of iron oxide NPs prepared 1 in 100% PEG
solution, 2 in 100% EG solution compared to control (0.89%) sodium
chloride solution
BioNanoSci.
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